Drug intelligence / Profile preview

Testavan

Development stage
Unknown
Lead developer
Ferring Pharmaceuticals
Modality
Small Molecules
Administration
Transdermal, Topical
01

Overview

Testavan is a branded 2% transdermal testosterone gel formulation used as testosterone replacement therapy in adult men with confirmed hypogonadism, delivering 20 mg testosterone per gram of gel via a metered pump and hands-free applicator for application to the upper arm and shoulder.[5][7][11] The active ingredient, testosterone, is an endogenous androgen that acts through the androgen receptor to restore physiological serum testosterone concentrations, supporting normal development and maintenance of male secondary sexual characteristics, sexual function, body composition, and overall quality of life.[5] Testavan uses a fast-drying gel base incorporating Ferring’s Advanced Skin Technology to enhance transdermal absorption and is positioned as an alternative to other transdermal testosterone preparations for patients requiring a non-oral, non-injectable delivery system.[2][5][8]

Brand names
TestavanTestarzon
Other names
testosterone 20 mg/g transdermal geltestosterone 2% transdermal geltestosterone gel 2%
02

Targets

AR (Adrenergic receptors)

Beyond the preview

Go deeper on Testavan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Testavan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call